Australia's most trusted source of pharma news
Wednesday, 15 August 2018
Lost Your Access?
CSL 17-18 profit skyrockets
Blood drug launches, vax sales drive revenue.
PM reveals meningo talks
Pfizer's Nimenrix likely focus of NIP negotiations.
Merck vs Merck hits Aust
Global battle over Merck name reaches local courts.
Pharma pulls out of Sky News
Pfizer, GSK suspend ads in protest.
Orkambi clears late hurdle
Eleventh hour TGA approval for CF drug.
Triplet pill surprises in BP
Aust study may change treatment globally.
Merck names new Aust MD
Sanofi VP comes home for top job.
Sigma a takeover target
CEO sees potential in a deal with Amazon.
Pharma reps peddle old news
Doctors accuse local reps of 'stale' content.
MA argument 'rubbish': Hooper
NPSA chair slams MA's exclusive distribution defense.
AZ names new marketing head
Novo Nordisk PA director moves to top divisional job.
AbbVie tweets hep C launch
Takes to social media to announce Mavyret's arrival.
'Too busy' for drug safety
Two in three pharmacists don't report adverse events.
No easy ride for MA chair
Lavelle speaks openly about challenges ahead.
AbbVie funds Aust start-up
Investigating hookworms to fight autoimmune disease.
NSW invests in CAR-T
New gene transfer device attracts $.5m from state.
Equity not the end game
Gender equality is a milestone, not ultimate success.
Copies for heart, depression drugs
Apotex and Alembic register generics
Japanese blood drug closer
FDA approves orphan with Aust plans.
Events & Conferences
© 2003 - 2018 Lush Media
Pharma in Focus
Jolly Good Design